echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Zhang Zemin's research team and collaborators reveal the mechanism of anti-PD-1 immunotherapy in lung cancer

    Zhang Zemin's research team and collaborators reveal the mechanism of anti-PD-1 immunotherapy in lung cancer

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On December 23, 2021, Peking University Biomedical Frontier Innovation Center (BIOPIC), School of Life Sciences, Beijing Future Gene Diagnosis Advanced Innovation Center (ICG) Zhang Zemin's research group and 301 Hospital Han Weidong's research group published in the international journal Nature Cancer A research paper entitled " Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer ", proposed the concept of clonal revival and revealed PD-1 The mechanism of action of antibody therapy in lung cancer


    Screenshot of the paper

    Immunotherapy represented by anti-PD-1 has significantly improved the pattern of cancer treatment, but immunotherapy only works in a part of cancer patients


    Figure 1.


    Tumor infiltrating T cells include not only tumor-specific T cells that can recognize tumor antigens and kill cancer cells, but also T cells that specifically recognize non-tumor antigens such as influenza viruses, and non-tumor-specific T cells account for a large portion of tumors Proportion [1]


    The researchers developed a new set of analysis ideas (Figure 1).


    There are three possibilities for the increase of tumor-specific T cell precursor cells after effective treatment: 1.


    In addition, the Howard Chang research group of Stanford University proposed the concept of clonal replacement, which believed that the clonal types of tumor-specific T cells in tumors after treatment were newly emerged [7]


    Figure 2.


    Baolin Liu, a doctoral student from the BIOPIC/School of Life Sciences at Peking University, Dr.


    references:


    [1] Simoni et al.


    [2] Caushi et al.


    [3] Oliveira et al.


    [4] Ahmadzadehet al.


    [5] van der Leun et al.


    [6] Pauken et al.


    [7] Yost et al.
    , Clonal replacement of tumor-specific T cells following PD-1 blockade, Nat.
    Med.
    (2019).

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.